BridgeMD
Compares treatment options for Amblyopia Unilateral
Official title AR Training Versus Patching in Unilateral Amblyopia
ClinicalTrials.gov ID: NCT06498206
What this study is testing
- What it's testing
- This is a multi-center, randomized controlled trial to compare the effectiveness of AR training with patching for the treatment of unilateral amblyopia. Specific Aim 1 (Primary): To compare the improvement of visual acuity in the amblyopic eye between AR training and patching for the treatment of unilateral amblyopia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 55
You may be able to join if
- Aged 5-55 years (including 5 years and 55 years);
- Best-corrected visual acuity worse than 20/30 but no worse than 20/200 in the amblyopic eye, interocular difference of 2 or more lines, with the...
- Patients have applied optical refractive correction for more than 3 months;
- Ability attend visits and complete the treatment;
- Normal binocular alignment including strabismic amblyopia with orthotropia after surgical correction, or intermittent exotropia within a range of -15...
You likely can't join if
- Organic eye diseases preventing the establishment of good vision (e.g. ptosis, media opacity, nystagmus, paracentral fixation, acute inflammation...
- Lesions of the brain preventing the establishment of good vision (e.g. cortical visual impairment);
- Implantable electronic device;
- A history of ocular surgery (except strabismus surgery) affecting vision (e.g. retinal detachment repair);
- A history of ocular trauma affecting vision;
- Receiving amblyopia therapy (except wearing glasses) within 2 weeks prior to presentation;
See the full eligibility criteria
- Aged 5-55 years (including 5 years and 55 years);
- Best-corrected visual acuity worse than 20/30 but no worse than 20/200 in the amblyopic eye, interocular difference of 2 or more lines, with the better eye within the normal range;
- Patients have applied optical refractive correction for more than 3 months;
- Ability attend visits and complete the treatment;
- Normal binocular alignment including strabismic amblyopia with orthotropia after surgical correction, or intermittent exotropia within a range of -15 to 0 prism diopters measured by the prism cover test.
- Organic eye diseases preventing the establishment of good vision (e.g. ptosis, media opacity, nystagmus, paracentral fixation, acute inflammation like keratitis, optic nerve diseases like glaucoma, retinal diseases);
- Lesions of the brain preventing the establishment of good vision (e.g. cortical visual impairment);
- Implantable electronic device;
- A history of ocular surgery (except strabismus surgery) affecting vision (e.g. retinal detachment repair);
- A history of ocular trauma affecting vision;
- Receiving amblyopia therapy (except wearing glasses) within 2 weeks prior to presentation;
- History of epilepsy or mental illness, or cognitive defects;
- Currently taking medications or needing to take medications during the study period that may affect vision;
- Inability to comply with the treatments or follow-up visits required;
- Participation in clinical trials on drugs within 3 months prior to presentation, or clinical trials on other medical devices within 30 days prior to presentation.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.